Physician
Carmody, Susan
Carmody, Susan was paid $596K by Medicaid between Jan 2018 and Sep 2024, across 17 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 47% of everything it billed.
33Billing provider infoCARMODY, SUSAN
BLOOMINGTON, IL 61701
BLOOMINGTON, IL 61701
33aNPI1841390481assigned 09/24/2006
33bProvider typeFamily Medicine Physician
28Total paid$596K
24GClaims13,780
24DCodes billed17
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Family Medicine Physician providers in Illinois
Rank by total paid#171 of 2,947
Median peer was paid$43K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,130 | $123K | |
| 2019 | 3,015 | $124K | |
| 2020 | 1,656 | $66K | |
| 2021 | 1,903 | $91K | |
| 2022 | 1,482 | $73K | |
| 2023 | 1,587 | $66K | |
| 2024incomplete | 1,007 | $53K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 47% | 6,565 | 5,697 | $282K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 40% | 3,526 | 3,079 | $238K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.0% | 1,539 | 1,354 | $24K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.5% | 486 | 421 | $15K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.6% | 402 | 254 | $10K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 176 | 156 | $7K |
| 87428 | 1.1% | 101 | 98 | $6K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.0% | 84 | 72 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 69 | 69 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 163 | 156 | $2K |
| 81002 | <1% | 479 | 411 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 26 | 18 | $379.61 |
5 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 37 | $369.30 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 33 | $353.56 |
| 90686 | <1% | 24 | $282.07 | |
| 81025 | <1% | 48 | $165.54 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 22 | $1.76 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.